Corcept Therapeutics | CORT - Los Gastos Financieros De La Deuda

Precio De Mercado
32.28
Cambio Diario
0.13 0.40%
Mensual
-18.55%
Anual
-44.23%
Q1 Expectativa
31.18




Los Gastos Financieros De La Deuda Cambio Fecha
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Alaunos Therapeutics USD 0 0 2023-12
ANI Pharmaceuticals USD 4.41M 316K 2025-12
Ardelyx USD 5.8M 784K 2025-09
Assertio Holdings USD 758K 1000 2024-06
Aurora Cannabis CAD 2.22M 442K 2025-09
BioMarin Pharmaceutical USD 2.78M 199K 2025-12
Bristol-Myers Squibb USD 432M 48M 2025-12
Canopy Growth CAD 8.8M 938K 2025-09
Corcept Therapeutics USD 823.61M 21.88M 2025-09
Eli Lilly USD 114.7M 134.3M 2025-09
Esperion Therapeutics USD 22.64M 585K 2025-12
J&J USD 18M 290M 2025-09
Knight Therapeutics CAD 2.37M 6K 2025-09
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
Merck USD 412M 85M 2025-12
Nektar Therapeutics USD 6.02M 420K 2024-09
Novartis USD 281M 8M 2025-09
Novartis USD 281M 8M 2025-09
Omeros USD 4.05M 5.16M 2024-09
Pacira USD 3.89M 387K 2025-12
Pfizer USD 711M 59M 2025-12
Supernus Pharmaceuticals USD 910K 278K 2023-06
TG Therapeutics USD 6.53M 187K 2025-12